Literature DB >> 21841783

Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport.

Kazuaki Ohtsubo1, Mark Z Chen, Jerrold M Olefsky, Jamey D Marth.   

Abstract

A connection between diet, obesity and diabetes exists in multiple species and is the basis of an escalating human health problem. The factors responsible provoke both insulin resistance and pancreatic beta cell dysfunction but remain to be fully identified. We report a combination of molecular events in human and mouse pancreatic beta cells, induced by elevated levels of free fatty acids or by administration of a high-fat diet with associated obesity, that comprise a pathogenic pathway to diabetes. Elevated concentrations of free fatty acids caused nuclear exclusion and reduced expression of the transcription factors FOXA2 and HNF1A in beta cells. This resulted in a deficit of GnT-4a glycosyltransferase expression in beta cells that produced signs of metabolic disease, including hyperglycemia, impaired glucose tolerance, hyperinsulinemia, hepatic steatosis and diminished insulin action in muscle and adipose tissues. Protection from disease was conferred by enforced beta cell-specific GnT-4a protein glycosylation and involved the maintenance of glucose transporter expression and the preservation of glucose transport. We observed that this pathogenic process was active in human islet cells obtained from donors with type 2 diabetes; thus, illuminating a pathway to disease implicated in the diet- and obesity-associated component of type 2 diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21841783      PMCID: PMC3888087          DOI: 10.1038/nm.2414

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  48 in total

1.  Foxa1 and Foxa2 maintain the metabolic and secretory features of the mature beta-cell.

Authors:  Nan Gao; John Le Lay; Wei Qin; Nicolai Doliba; Jonathan Schug; Alan J Fox; Olga Smirnova; Franz M Matschinsky; Klaus H Kaestner
Journal:  Mol Endocrinol       Date:  2010-06-09

2.  Underexpression of beta cell high Km glucose transporters in noninsulin-dependent diabetes.

Authors:  J H Johnson; A Ogawa; L Chen; L Orci; C B Newgard; T Alam; R H Unger
Journal:  Science       Date:  1990-10-26       Impact factor: 47.728

3.  Evidence that down-regulation of beta-cell glucose transporters in non-insulin-dependent diabetes may be the cause of diabetic hyperglycemia.

Authors:  L Orci; M Ravazzola; D Baetens; L Inman; M Amherdt; R G Peterson; C B Newgard; J H Johnson; R H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

4.  Reduced beta-cell glucose transporter in new onset diabetic BB rats.

Authors:  L Orci; R H Unger; M Ravazzola; A Ogawa; I Komiya; D Baetens; H F Lodish; B Thorens
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

5.  Diet-induced type II diabetes in C57BL/6J mice.

Authors:  R S Surwit; C M Kuhn; C Cochrane; J A McCubbin; M N Feinglos
Journal:  Diabetes       Date:  1988-09       Impact factor: 9.461

6.  Reduced expression of the liver/beta-cell glucose transporter isoform in glucose-insensitive pancreatic beta cells of diabetic rats.

Authors:  B Thorens; G C Weir; J L Leahy; H F Lodish; S Bonner-Weir
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

7.  Expression of GLUT-2 antisense RNA in beta cells of transgenic mice leads to diabetes.

Authors:  A Valera; G Solanes; J Fernández-Alvarez; A Pujol; J Ferrer; G Asins; R Gomis; F Bosch
Journal:  J Biol Chem       Date:  1994-11-18       Impact factor: 5.157

8.  Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression.

Authors:  A De Vos; H Heimberg; E Quartier; P Huypens; L Bouwens; D Pipeleers; F Schuit
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

9.  Glucose-induced phosphorylation of the insulin receptor. Functional effects and characterization of phosphorylation sites.

Authors:  T S Pillay; S Xiao; J M Olefsky
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

Review 10.  Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications.

Authors:  R H Unger
Journal:  Diabetes       Date:  1995-08       Impact factor: 9.461

View more
  86 in total

Review 1.  Regulated expression and neural functions of human natural killer-1 (HNK-1) carbohydrate.

Authors:  Yasuhiko Kizuka; Shogo Oka
Journal:  Cell Mol Life Sci       Date:  2012-06-06       Impact factor: 9.261

Review 2.  Genomics and epigenomics of the human glycome.

Authors:  Vlatka Zoldoš; Mislav Novokmet; Ivona Bečeheli; Gordan Lauc
Journal:  Glycoconj J       Date:  2012-05-31       Impact factor: 2.916

Review 3.  Glycosylation of solute carriers: mechanisms and functional consequences.

Authors:  Nis Borbye Pedersen; Michael C Carlsson; Stine Falsig Pedersen
Journal:  Pflugers Arch       Date:  2015-09-18       Impact factor: 3.657

4.  Novel protein glycan side-chain biomarker and risk of incident type 2 diabetes mellitus.

Authors:  Akintunde O Akinkuolie; Aruna D Pradhan; Julie E Buring; Paul M Ridker; Samia Mora
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-04-23       Impact factor: 8.311

5.  Preserving Mafa expression in diabetic islet β-cells improves glycemic control in vivo.

Authors:  Taka-aki Matsuoka; Hideaki Kaneto; Satoshi Kawashima; Takeshi Miyatsuka; Yoshihiro Tochino; Atsushi Yoshikawa; Akihisa Imagawa; Jun-ichi Miyazaki; Maureen Gannon; Roland Stein; Iichiro Shimomura
Journal:  J Biol Chem       Date:  2015-02-02       Impact factor: 5.157

6.  Inducing host protection in pneumococcal sepsis by preactivation of the Ashwell-Morell receptor.

Authors:  Prabhjit K Grewal; Peter V Aziz; Satoshi Uchiyama; Gabriel R Rubio; Ricardo D Lardone; Dzung Le; Nissi M Varki; Victor Nizet; Jamey D Marth
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-27       Impact factor: 11.205

7.  Bisecting GlcNAc Is a General Suppressor of Terminal Modification of N-glycan.

Authors:  Miyako Nakano; Sushil K Mishra; Yuko Tokoro; Keiko Sato; Kazuki Nakajima; Yoshiki Yamaguchi; Naoyuki Taniguchi; Yasuhiko Kizuka
Journal:  Mol Cell Proteomics       Date:  2019-08-02       Impact factor: 5.911

Review 8.  Neural functions of bisecting GlcNAc.

Authors:  Yasuhiko Kizuka; Naoyuki Taniguchi
Journal:  Glycoconj J       Date:  2018-06-16       Impact factor: 2.916

9.  20-HETE attenuates the response of glucose-stimulated insulin secretion through the AKT/GSK-3β/Glut2 pathway.

Authors:  Bijun Zhang; Guangrui Lai; Jingjing Wu; Ru Sun; Runhong Xu; Xianghong Yang; Yafei Qi; Yanyan Zhao
Journal:  Endocrine       Date:  2016-08-27       Impact factor: 3.633

10.  Increased plasma N-glycome complexity is associated with higher risk of type 2 diabetes.

Authors:  Toma Keser; Ivan Gornik; Frano Vučković; Najda Selak; Tamara Pavić; Edita Lukić; Ivan Gudelj; Hrvoje Gašparović; Bojan Biočina; Therese Tilin; Annika Wennerström; Satu Männistö; Veikko Salomaa; Aki Havulinna; Wei Wang; James F Wilson; Nish Chaturvedi; Markus Perola; Harry Campbell; Gordan Lauc; Olga Gornik
Journal:  Diabetologia       Date:  2017-09-13       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.